153 related articles for article (PubMed ID: 31662413)
1. An Ultrasensitive LC-APPI-MS/MS Method for Simultaneous Determination of Ciclesonide and Active Metabolite Desisobutyryl-Ciclesonide in Human Serum and Its Application to a Clinical Study.
Chen YL; Wang W; Gatien Ngounou Wetie A; Shi L; Eddy J; John Lin ZP; Sunkaraneni S
J Appl Lab Med; 2020 Jan; 5(1):41-53. PubMed ID: 31662413
[TBL] [Abstract][Full Text] [Related]
2. Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC-MS/MS with APPI.
Mascher HJ; Zech K; Mascher DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):84-92. PubMed ID: 18514597
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of ciclesonide and its active metabolite desisobutyryl-ciclesonide in human plasma by LC-APCI-MS/MS: application to pharmacokinetic study in healthy Chinese volunteers.
Su MX; Song M; Zhuang Y; Wang YQ; Hang TJ
J Pharm Biomed Anal; 2011 Apr; 55(1):230-5. PubMed ID: 21296519
[TBL] [Abstract][Full Text] [Related]
4. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
Drollmann A; Nave R; Steinijans VW; Baumgärtner E; Bethke TD
Clin Pharmacokinet; 2006; 45(7):729-36. PubMed ID: 16802853
[TBL] [Abstract][Full Text] [Related]
5. LC-HRMS/MS study of the prodrug ciclesonide and its active metabolite desisobutyryl-ciclesonide in plasma after an inhalative administration to horses for doping control purposes.
Trevisiol S; Moulard Y; Kaabia Z; Delcourt V; Loup B; Garcia P; Boyer S; Dauriac K; Groseille G; Rouger S; Narbe R; Popot MA; Bailly-Chouriberry L
Drug Test Anal; 2022 Feb; 14(2):252-261. PubMed ID: 34634175
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
Nave R; Herzog R; Laurent A; Wingertzahn MA
Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
Nave R; Gunawardena KA; Zech K; Bethke TD
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):1-7. PubMed ID: 16425964
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
[TBL] [Abstract][Full Text] [Related]
9. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide.
Nave R; Meyer W; Fuhst R; Zech K
Pulm Pharmacol Ther; 2005; 18(6):390-6. PubMed ID: 16179214
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
Nave R; Bethke TD; van Marle SP; Zech K
Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
[TBL] [Abstract][Full Text] [Related]
11. Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-μm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging.
Yamamoto E; Taquahashi Y; Kuwagata M; Saito H; Matsushita K; Toyoda T; Sato F; Kitajima S; Ogawa K; Izutsu KI; Saito Y; Hirabayashi Y; Iimura Y; Honma M; Okuda H; Goda Y
Int J Pharm; 2021 Feb; 595():120241. PubMed ID: 33484917
[TBL] [Abstract][Full Text] [Related]
12. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
Nave R; Zech K; Bethke TD
Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
[TBL] [Abstract][Full Text] [Related]
13. Determination of lung deposition following inhalation of ciclesonide using different bioanalytical procedures.
Nave R
Bioanalysis; 2010 Apr; 2(4):807-14. PubMed ID: 21083275
[TBL] [Abstract][Full Text] [Related]
14. Ciclesonide disposition and metabolism: pharmacokinetics, metabolism, and excretion in the mouse, rat, rabbit, and dog.
Guo Z; Gu Z; Howell SR; Chen K; Rohatagi S; Cai L; Wu J; Stuhler J
Am J Ther; 2006; 13(6):490-501. PubMed ID: 17122529
[TBL] [Abstract][Full Text] [Related]
15. Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study.
Teramoto T; Matsui E; Fukao T; Sakai K; Yonezawa H; Kato Z; Ohnishi H; Kaneko H; Kondo N; Azuma J; Nishima S
Allergol Int; 2012 Dec; 61(4):619-24. PubMed ID: 23000724
[TBL] [Abstract][Full Text] [Related]
16. Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa.
Sato H; Nave R; Nonaka T; Yoshihisa N; Atsuhiro N; Mochizuki T; Takahama S; Kondo S; Wingertzahn M
BMC Pharmacol; 2007 Jun; 7():7. PubMed ID: 17553148
[TBL] [Abstract][Full Text] [Related]
17. Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model.
Rohatagi S; Krishnaswami S; Pfister M; Sahasranaman S
Am J Ther; 2005; 12(5):385-97. PubMed ID: 16148423
[TBL] [Abstract][Full Text] [Related]
18. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
Newman S; Salmon A; Nave R; Drollmann A
Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
[TBL] [Abstract][Full Text] [Related]
19. Deposition and metabolism of inhaled ciclesonide in the human lung.
Nave R; Watz H; Hoffmann H; Boss H; Magnussen H
Eur Respir J; 2010 Nov; 36(5):1113-9. PubMed ID: 20351025
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
Xu J; Nave R; Lahu G; Derom E; Derendorf H
J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
